Key Points
-
Shortage of organs limits the number of heart transplantations performed; waiting-list mortality is 10–12% per year in Europe and the USA
-
Adoption of donation after circulatory determination of death (DCDD) in heart transplantation could substantially improve organ availability for both adults and children
-
Very limited clinical evidence already supports the feasibility of heart transplantation with DCDD
-
Tissue injury resulting from exposure of the donor heart to warm, noncardioplegic ischaemia before procurement is the major obstacle for DCDD in heart transplantation
-
Strategies for procurement, storage, and evaluation must be optimized for DCDD in heart transplantation; effective approaches remain to be identified
-
Establishment of DCDD in heart transplantation also requires careful consideration of ethical and legal aspects
Abstract
The constant shortage of available organs is a major obstacle and limiting factor in heart transplantation; the discrepancy between the number of donors and potential recipients leads to waiting-list mortality of 10–12% per year in Europe and the USA. If adopted for heart transplantation, donation after circulatory determination of death (DCDD) would be expected to improve the availability of organs substantially for both adults and children. With DCDD, however, hearts to be transplanted undergo a period of warm ischaemia before procurement, which is of particular concern because tissue damage occurs rapidly and might be sufficient to preclude transplantation. Nonetheless, the heart is able to withstand limited periods of warm ischaemia, which could provide a window of opportunity for DCDD. Development of clinical approaches specifically for DCDD is critical for the exploitation of these organs, because current practices for donor heart procurement, evaluation, and storage have been optimized for conventional donation after brain death, without consideration of warm ischaemia before organ procurement. Establishment of clinical protocols and ethical and legal frameworks for DCDD of other organs is underway. This Review provides a timely evaluation of the potential for DCDD in heart transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Council of Europe. International figures on donation and transplantation 2010 (ed. Matesanz, R). Newsletter Transplant. 16, 1–80 (2011).
Council of Europe. International figures on donation and transplantation 2011 (ed. Matesanz, R). Newsletter Transplant. 17, 1–92 (2012).
Osaki, S., Anderson, J. E., Johnson, M. R., Edwards, N. M. & Kohmoto, T. The potential of cardiac allografts from donors after cardiac death at the University of Wisconsin Organ Procurement Organization. Eur. J. Cardiothorac. Surg. 37, 74–79 (2010).
Manara, A. R., Murphy, P. G. & O'Callaghan, G. Donation after circulatory death. Br. J. Anaesth. 108 (Suppl. 1), i108–i121 (2012).
Singhal, A. K. et al. Potential suitability for transplantation of hearts from human non-heart-beating donors: data review from the Gift of Life Donor Program. J. Heart Lung Transplant. 24, 1657–1664 (2005).
Noterdaeme, T. et al. What is the potential increase in the heart graft pool by cardiac donation after circulatory death? Transpl. Int. 26, 61–66 (2013).
Koogler, T. & Costarino, A. T. Jr. The potential benefits of the pediatric nonheartbeating organ donor. Pediatrics 101, 1049–1052 (1998).
Pleacher, K. M., Roach, E. S., Van der Werf, W., Antommaria, A. H. & Bratton, S. L. Impact of a pediatric donation after cardiac death program. Pediatr. Crit. Care Med. 10, 166–170 (2009).
Whetstine, L., Bowman, K. & Hawryluck, L. Pro/con ethics debate: is nonheart-beating organ donation ethically acceptable? Crit. Care 6, 192–195 (2002).
Ali, A. et al. Cardiac recovery in a human non-heart-beating donor after extracorporeal perfusion: source for human heart donation? J. Heart Lung Transplant. 28, 290–293 (2009).
Rosenfeldt, F., Ou, R., Woodard, J., Esmore, D. & Marasco, S. Twelve-hour reanimation of a human heart following donation after circulatory death. Heart Lung Circ. 23, 88–90 (2014).
Boucek, M. M. et al. Pediatric heart transplantation after declaration of cardiocirculatory death. N. Engl. J. Med. 359, 709–714 (2008).
Chiu, K. M., Lin, T. Y. & Chu, S. H. Successful heterotopic heart transplant after cardiopulmonary bypass rescue of an arrested donor heart. Transplant. Proc. 38, 1514–1515 (2006).
Kootstra, G., Daemen, J. H. & Oomen, A. P. Categories of non-heart-beating donors. Transplant. Proc. 27, 2893–2894 (1995).
Sanchez-Fructuoso, A. I. et al. Renal transplantation from non-heart beating donors: a promising alternative to enlarge the donor pool. J. Am. Soc. Nephrol. 11, 350–358 (2000).
Bernat, J. L. et al. Circulatory death determination in uncontrolled organ donors: a panel viewpoint. Ann. Emerg. Med. 63, 384–390 (2014).
Barnard, C. N. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S. Afr. Med. J. 41, 1271–1274 (1967).
Monbaliu, D., Pirenne, J. & Talbot, D. Liver transplantation using donation after cardiac death donors. J. Hepatol. 56, 474–485 (2012).
Manno, E. M. Nonheart-beating donation in the neurologically devastated patient. Neurocrit. Care 3, 111–114 (2005).
Dominguez-Gil, B. et al. Current situation of donation after circulatory death in European countries. Transpl. Int. 24, 676–686 (2011).
Dipchand, A. I. et al. Ten yr of pediatric heart transplantation: a report from the Pediatric Heart Transplant Study. Pediatr. Transplant. 17, 99–111 (2013).
Magee, J. C. et al. Pediatric transplantation. Am. J. Transplant. 4 (Suppl. 9), 54–71 (2004).
Mathur, M., Castleberry, D. & Job, L. Identifying potential heart donors among newborns undergoing circulatory determination of death. J. Heart Lung Transplant. 30, 389–394 (2011).
Fraser, J. et al. The potential for non-heart beating organ donation within a paediatric intensive care unit. Arch. Dis. Child. 96, 932–935 (2011).
Durall, A. L., Laussen, P. C. & Randolph, A. G. Potential for donation after cardiac death in a children's hospital. Pediatrics 119, e219–e224 (2007).
Dark, J. H. Lung transplantation from the non-heart beating donor. Transplantation 86, 200–201 (2008).
Snell, G. I. et al. Effect of multiorgan donation after cardiac death retrieval on lung performance. ANZ J. Surg. 78, 262–265 (2008).
Goldsmith, P. J. et al. Outcomes following renal transplantation after multiorgan retrieval versus kidney-only retrieval in donation after cardiac death donors. Transplant. Proc. 42, 3963–3965 (2010).
NHS Blood and Transplant. National standards for organ retrieval from deceased donors [online], (2013).
Hirota, M. et al. Prediction of functional recovery of 60-minute warm ischemic hearts from asphyxiated canine non-heart-beating donors. J. Heart Lung Transplant. 25, 339–344 (2006).
Hirota, M., Ishino, K., Tedoriya, T. & Sano, S. Post-mortem tissue-type plasminogen activator preserves graft function of hearts harvested from non-pre-treated non-heart-beating donors. J. Heart Lung Transplant. 29, 888–893 (2010).
Kotani, Y. et al. Efficacy of MCI-186, a free-radical scavenger and antioxidant, for resuscitation of nonbeating donor hearts. J. Thorac. Cardiovasc. Surg. 133, 1626–1632 (2007).
Osaki, S. et al. Resuscitation of non-beating donor hearts using continuous myocardial perfusion: the importance of controlled initial reperfusion. Ann. Thorac. Surg. 81, 2167–2171 (2006).
Osaki, S. et al. Circulatory load during hypoxia impairs post-transplant myocardial functional recovery in donation after cardiac death. J. Heart Lung Transplant. 28, 266–272 (2009).
Stadelmann, M. et al. Mild hypothermia during global cardiac ischemia opens a window of opportunity to develop heart donation after cardiac death. Transpl. Int. 26, 339–348 (2013).
Dornbierer, M. et al. Early reperfusion hemodynamics predict recovery in rat hearts: a potential approach towards evaluating cardiac grafts from non-heart-beating donors. PLoS ONE 7, e43642 (2012).
Bernat, J. L. The boundaries of organ donation after circulatory death. N. Engl. J. Med. 359, 669–671 (2008).
Chaib, E. Non heart-beating donors in England. Clinics 63, 121–134 (2008).
Rustad et al. Heart transplant systolic and diastolic function is impaired by prolonged pretransplant graft ischaemic time and high donor age: an echocardiographic study. Eur. J. Cardiothorac. Surg. 44, e97–e104 (2013).
Kato, G. et al. Efficacy of an endothelin-A receptor antagonist in heart transplantation from asphyxiated canine non-heart-beating donors. Jpn. J. Thorac. Cardiovasc. Surg. 54, 511–515 (2006).
Zhao, Z. Q. & Vinten-Johansen, J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc. Res. 70, 200–211 (2006).
Bell, R. M., Mocanu, M. M. & Yellon, D. M. Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J. Mol. Cell. Cardiol. 50, 940–950 (2011).
Hausenloy, D. J. & Yellon, D. M. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis 204, 334–341 (2009).
Doenst, T. et al. Three good reasons for heart surgeons to understand cardiac metabolism. Eur. J. Cardiothorac. Surg. 33, 862–871 (2008).
Fugate, J. E., Stadtler, M., Rabinstein, A. A. & Wijdicks, E. F. Variability in donation after cardiac death protocols: a national survey. Transplantation 91, 386–389 (2011).
Gries, C. J. et al. An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determination of death. Am. J. Respir. Crit. Care Med. 188, 103–109 (2013).
The Australian and New Zealand Intensive Care Society. The ANZICS Statement on Death and Organ Donation Edition 3.2 [online], (2013).
Richards, B. & Rogers, W. A. Organ donation after cardiac death: legal and ethical justifications for antemortem interventions. Med. J. Aust. 187, 168–170 (2007).
Sivaraman, V. & Yellon, D. M. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury. J. Cardiovasc. Pharmacol. Ther. 19, 83–96 (2014).
Gerczuk, P. Z. & Kloner, R. A. Protecting the heart from ischemia: an update on ischemic and pharmacologic conditioning. Hosp. Pract. (1995) 39, 35–43 (2011).
Cohen, M. V. & Downey, J. M. Is it time to translate ischemic preconditioning's mechanism of cardioprotection into clinical practice? J. Cardiovasc. Pharmacol. Ther. 16, 273–280 (2011).
D'Ascenzo, F. et al. Remote ischaemic preconditioning in coronary artery bypass surgery: a meta-analysis. Heart 98, 1267–1271 (2012).
Kloner, R. A. Current state of clinical translation of cardioprotective agents for acute myocardial infarction. Circ. Res. 113, 451–463 (2013).
Marczak, J., Nowicki, R., Kulbacka, J. & Saczko, J. Is remote ischaemic preconditioning of benefit to patients undergoing cardiac surgery? Interact. Cardiovasc. Thorac. Surg. 14, 634–639 (2012).
Zhou, C. et al. β-Blockers and volatile anesthetics may attenuate cardioprotection by remote preconditioning in adult cardiac surgery: a meta-analysis of 15 randomized trials. J. Cardiothorac. Vasc. Anesth. 27, 305–311 (2013).
Przyklenk, K. Reduction of myocardial infarct size with ischemic “conditioning”: physiologic and technical considerations. Anesth. Analg. 117, 891–901 (2013).
Thielmann, M. et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 382, 597–604 (2013).
Hausenloy, D. J. et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370, 575–579 (2007).
Pagel, P. S. & Hudetz, J. A. Delayed cardioprotection by inhaled anesthetics. J. Cardiothorac. Vasc. Anesth. 25, 1125–1140 (2011).
Landoni, G., Fochi, O. & Torri, G. Cardiac protection by volatile anaesthetics: a review. Curr. Vasc. Pharmacol. 6, 108–111 (2008).
Landoni, G., Turi, S., Bignami, E. & Zangrillo, A. Organ protection by volatile anesthetics in non-coronary artery bypass grafting surgery. Future Cardiol. 5, 589–603 (2009).
Tissier, R., Ghaleh, B., Cohen, M. V., Downey, J. M. & Berdeaux, A. Myocardial protection with mild hypothermia. Cardiovasc. Res. 94, 217–225 (2012).
Chien, G. L., Wolff, R. A., Davis, R. F. & van Winkle, D. M. “Normothermic range” temperature affects myocardial infarct size. Cardiovasc. Res. 28, 1014–1017 (1994).
Jones, R. N., Reimer, K. A., Hill, M. L. & Jennings, R. B. Effect of hypothermia on changes in high-energy phosphate production and utilization in total ischemia. J. Mol. Cell. Cardiol. 14 (Suppl. 3), 123–130 (1982).
Hayashida, N. et al. Tepid antegrade and retrograde cardioplegia. Ann. Thorac. Surg. 59, 723–729 (1995).
Tissier, R. et al. The small chill: mild hypothermia for cardioprotection? Cardiovasc. Res. 88, 406–414 (2010).
Shao, Z. H. et al. Therapeutic hypothermia cardioprotection via Akt- and nitric oxide-mediated attenuation of mitochondrial oxidants. Am. J. Physiol. Heart Circ. Physiol. 298, H2164–H2173 (2010).
Mochizuki, T., Yu, S., Katoh, T., Aoki, K. & Sato, S. Cardioprotective effect of therapeutic hypothermia at 34°C against ischaemia/reperfusion injury mediated by PI3K and nitric oxide in a rat isolated heart model. Resuscitation 83, 238–242 (2012).
Lampe, J. W. & Becker, L. B. State of the art in therapeutic hypothermia. Annu. Rev. Med. 62, 79–93 (2011).
Castrén, M. et al. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation 122, 729–736 (2010).
Miki, T., Liu, G. S., Cohen, M. V. & Downey, J. M. Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction? Basic Res. Cardiol. 93, 372–383 (1998).
Hausenloy, D. J. Signalling pathways in ischaemic postconditioning. Thromb. Haemost. 101, 626–634 (2009).
Hearse, D. J. Myocardial protection during ischemia and reperfusion. Mol. Cell. Biochem. 186, 177–184 (1998).
Mockford, K. A., Girn, H. R. & Homer-Vanniasinkam, S. Postconditioning: current controversies and clinical implications. Eur. J. Vasc. Endovasc. Surg. 37, 437–442 (2009).
Zhao, Z. Q. et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 285, H579–H588 (2003).
Hausenloy, D. J., Lecour, S. & Yellon, D. M. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid. Redox Signal. 14, 893–907 (2011).
Hausenloy, D. J. & Yellon, D. M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc. Res. 61, 448–460 (2004).
Lecour, S. Activation of the protective survivor activating factor enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway? J. Mol. Cell. Cardiol. 47, 32–40 (2009).
Correa, F. et al. Post-conditioning preserves glycolytic ATP during early reperfusion: a survival mechanism for the reperfused heart. Cell. Physiol. Biochem. 22, 635–644 (2008).
Lauzier, B. et al. After four hours of cold ischemia and cardioplegic protocol, the heart can still be rescued with postconditioning. Transplantation 84, 1474–1482 (2007).
Hausenloy, D. J. & Yellon, D. M. The therapeutic potential of ischemic conditioning: an update. Nat. Rev. Cardiol. 8, 619–629 (2011).
Hausenloy, D. J., Boston-Griffiths, E. & Yellon, D. M. Cardioprotection during cardiac surgery. Cardiovasc. Res. 94, 253–265 (2012).
Stanley, W. C., Recchia, F. A. & Lopaschuk, G. D. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093–1129 (2005).
Doenst, T. et al. Insulin improves functional and metabolic recovery of reperfused working rat heart. Ann. Thorac. Surg. 67, 1682–1688 (1999).
Zaha, V., Francischetti, I. & Doenst, T. Insulin improves postischemic recovery of function through PI3K in isolated working rat heart. Mol. Cell. Biochem. 247, 229–232 (2003).
Lopaschuk, G. D. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated? Coron. Artery Dis. 12 (Suppl. 1), S8–S11 (2001).
Cheung, N. W. Glucose control during acute myocardial infarction. Intern Med. J. 38, 345–348 (2008).
Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121–1135 (2007).
Argaud, L. et al. Postconditioning inhibits mitochondrial permeability transition. Circulation 111, 194–197 (2005).
Cohen, M. V., Yang, X. M. & Downey, J. M. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115, 1895–1903 (2007).
Honda, H. M., Korge, P. & Weiss, J. N. Mitochondria and ischemia/reperfusion injury. Ann. N. Y. Acad. Sci. 1047, 248–258 (2005).
Hausenloy, D. J., Maddock, H. L., Baxter, G. F. & Yellon, D. M. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc. Res. 55, 534–543 (2002).
Perrelli, M. G., Pagilaro, P. & Penna, C. Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J. Cardiol. 3, 186–200 (2011).
Guarini, G. et al. Therapy against ischemic injury. Curr. Pharm. Des. 19, 4597–4621 (2013).
Morel, O. et al. Pharmacological approaches to reperfusion therapy. Cardiovasc. Res. 94, 246–252 (2012).
Ivanes, F. et al. Cardioprotection in the clinical setting. Cardiovasc. Drugs Ther. 24, 281–287 (2010).
Ivanes, F., Rioufol, G., Piot, C. & Ovize, M. Postconditioning in acute myocardial infarction patients. Antioxid. Redox Signal. 14, 811–820 (2011).
Gomez, L. et al. Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovasc. Res. 83, 226–233 (2009).
Thatte, H. S. et al. Development and evaluation of a novel solution, Somah, for the procurement and preservation of beating and nonbeating donor hearts for transplantation. Circulation 120, 1704–1713 (2009).
Illes, R. W., Asimakis, G. K., Inners-McBride, K. & Buckingham, E. D. Recovery of nonbeating donor hearts. J. Heart Lung Transplant. 14, 553–561 (1995).
Martin, J. et al. Successful orthotopic pig heart transplantation from non-heart-beating donors. J. Heart Lung Transplant. 18, 597–606 (1999).
White, C. W. et al. A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death. J. Heart Lung Transplant. 32, 734–743 (2013).
Koike, N. et al. Effects of adding P38 mitogen-activated protein-kinase inhibitor to celsior solution in canine heart transplantation from non-heart-beating donors. Transplantation 77, 286–292 (2004).
Scheule, A. M. et al. Sodium-hydrogen inhibitor cariporide (HOE 642) improves in situ protection of hearts from non-heart-beating donors. J. Heart Lung Transplant. 22, 1335–1342 (2003).
Repse, S., Pepe, S., Anderson, J., McLean, C. & Rosenfeldt, F. L. Cardiac reanimation for donor heart transplantation after cardiocirculatory death. J. Heart Lung Transplant. 29, 747–755 (2010).
Scheule, A. M. et al. A non-heart-beating donor model to evaluate functional and morphologic outcomes in resuscitated pig hearts. J. Invest. Surg. 15, 125–135 (2002).
Collins, M. J., Moainie, S. L., Griffith, B. P. & Poston, R. S. Preserving and evaluating hearts with ex vivo machine perfusion: an avenue to improve early graft performance and expand the donor pool. Eur. J. Cardiothorac. Surg. 34, 318–325 (2008).
Koike, N. et al. The effect of short-term coronary perfusion using a perfusion apparatus on canine heart transplantation from non-heart-beating donors. J. Heart Lung Transplant. 22, 810–817 (2003).
Esmailian, F. et al. The PROCEED II International Heart Transplant Trial with the Organ Care System Technology (OCS). J. Heart Lung Transplant. 32 (Suppl.), S95–S96 (2013).
Ferrera, R., Bopassa, J. C., Rodriguez, C., Baverel, G. & Ovize, M. A simple and reliable method to assess heart viability after hypothermic procurement. Transplant. Proc. 38, 2283–2284 (2006).
Ferrera, R., Forrat, R., Marcsek, P., de Lorgeril, M. & Dureau, G. Importance of initial coronary artery flow after heart procurement to assess heart viability before transplantation. Circulation 91, 257–261 (1995).
Suehiro, K. et al. Posttransplant function of a nonbeating heart is predictable by an ex vivo perfusion method. Ann. Thorac. Surg. 71, 278–283 (2001).
Collins, M. J. et al. Use of diffusion tensor imaging to predict myocardial viability after warm global ischemia: possible avenue for use of non-beating donor hearts. J. Heart Lung Transplant. 26, 376–383 (2007).
Sourdon, J. et al. Cardiac transplantation with hearts from donors after circulatory declaration of death: haemodynamic and biochemical parameters at procurement predict recovery following cardioplegic storage in a rat model. Eur. J. Cardiothorac. Surg. 44, e87–e96 (2013).
Wells, A. C. et al. Donor kidney disease and transplant outcome for kidneys donated after cardiac death. Br. J. Surg. 96, 299–304 (2009).
Thomas, H. L. et al. Incidence and outcome of Levitronix CentriMag support as rescue therapy for early cardiac allograft failure: a United Kingdom national study. Eur. J. Cardiothorac. Surg. 40, 1348–1354 (2011).
Curfman, G. D., Morrissey, S. & Drazen, J. M. Cardiac transplantation in infants. N. Engl. J. Med. 359, 749–750 (2008).
Gardiner, D., Shemie, S., Manara, A. & Opdam, H. International perspective on the diagnosis of death. Br. J. Anaesth. 108 (Suppl. 1), i14–i28 (2012).
Shemie, S. D. et al. National recommendations for donation after cardiocirculatory death in Canada: donation after cardiocirculatory death in Canada. CMAJ 175, S1–S24 (2006).
Huang, J. et al. The national program for deceased organ donation in China. Transplantation 96, 5–9 (2013).
Bruzzone, P. Ethical and legal issues in donation after cardiac death in Italy. Transplant. Proc. 42, 1046–1047 (2010).
DeVita, M. A. The death watch: certifying death using cardiac criteria. Prog. Transplant. 11, 58–66 (2001).
Acknowledgements
To limit the number of references, reviews have occasionally been cited and the authors apologize to the authors of original papers for not citing them directly. The authors thank L. Seidel (Department of Cardiovascular Surgery, Inselspital, Berne University Hospital and University of Berne, Switzerland) for administrative assistance. The authors are supported by the Swiss National Science Foundation (grant number 310030_149730).
Author information
Authors and Affiliations
Contributions
S.L.L., V.M., and H.T.T. researched data for the article. S.L.L., M.D., F.D., T.P.C., and H.T.T. contributed substantially to discussion of its content. S.L.L, V.M., M.D., and H.T.T. wrote the manuscript, and S.L.L., F.D., T.P.C., and H.T.T. reviewed/edited the article before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Longnus, S., Mathys, V., Dornbierer, M. et al. Heart transplantation with donation after circulatory determination of death. Nat Rev Cardiol 11, 354–363 (2014). https://doi.org/10.1038/nrcardio.2014.45
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2014.45
This article is cited by
-
Enhanced Cardiac S100A1 Expression Improves Recovery from Global Ischemia-Reperfusion Injury
Journal of Cardiovascular Translational Research (2018)
-
Heart donation after circulatory determination of death: ethically acceptable?
Nature Reviews Cardiology (2014)